M11.0
Hydroxyapatite deposition disease
Clinical Classification Guidelines
Medical Intelligence & Overview
Hydroxyapatite Deposition Disease (HADD) is a condition characterized by the accumulation of hydroxyapatite crystals in soft tissues, such as tendons, bursae, and other connective tissues. This buildup can lead to inflammation, pain, and limited mobility. Although it can affect various parts of the body, it is most commonly seen in the shoulder, hip, and elbow areas. The condition is known for its sudden onset of symptoms and can significantly impact daily activities if left untreated.
Causes & Symptoms
Clinical Causes: Degeneration of tendons or tissues due to aging Repetitive injuries or overuse of joints Trauma or injury to soft tissues Metabolic factors influencing calcium and phosphate levels Genetic predispositions affecting tissue mineralization Previous inflammatory conditions or infections
Key Symptoms: Sudden and severe pain in the affected area Swelling and tenderness around tendons or bursae Limited range of motion in joints A palpable or visible bump or mass over the affected tissue Increased sensitivity to touch Possible warmth or redness indicating inflammation
Diagnostic & Treatment
Diagnosis Path: Diagnosing hydroxyapatite deposition disease involves a combination of clinical examination and imaging tests. Healthcare providers may perform the following:
Treatment Protocols: Managing hydroxyapatite deposition disease aims to alleviate symptoms and reduce inflammation. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is M11.0 a billable ICD-10 code?
Yes, M11.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M11.0?
Clinical documentation must specify the nature of Hydroxyapatite deposition disease and any associated comorbidities for accurate reporting.
Cite this Clinical Reference